New Zealand shares edged higher as gains in local software companies spurred on by Wall Street's tech rally just offset the general malaise of the latest covid-19 lockdown.

Reserve Bank stimulus helped soften a fall by New Zealand equities as investors reacted to a covid-19 flare-up which has put Auckland back into a level-3 lockdown.

New Zealand shares fell as investors rotated out of the best-performing stocks such as Fisher & Paykel Healthcare, and into some of the cheaper, beat-up firms including Air New Zealand, on the prospect of their recovery.

Shares in New Zealand’s benchmark index were buoyed by strength in the Australian market and an as-expected earnings report from Contact Energy.

New Zealand shares fell after Rio Tinto quashed rumours production was ramping up at the Tiwai Point aluminium smelter; Fisher & Paykel Healthcare fell after rival ResMed reported disappointing earnings.

New Zealand shares edged higher as rumours of negotiations to delay closing the Tiwai Point aluminium smelter pushed Contact Energy and Meridian Energy higher. Exporters A2 Milk and Fisher & Paykel Healthcare fell.

New Zealand shares edged lower and gold hit another record as investors focused on the lingering uncertainty caused by the number of coronavirus cases continuing to rise globally.

New Zealand shares joined a rally across Asia as better than expected US and European manufacturing figures revived investors' confidence in the global economy. Fisher & Paykel Healthcare led the market higher.

New Zealand shares fell as new lockdown measures - placed over parts of Australia to stem a resurgence of covid-19 - weighed down financial and travel stocks on the local market. Fruit exporter Scales dropped on downgraded earnings.

New Zealand shares rose as earnings updates from local firms and US tech companies outweighed data showing a record quarterly contraction for the US economy. Mainfreight hit an all-time high.

New Zealand shares were buoyed by property stocks on news that Stride Property was maintaining its dividend despite the impacts of the covid-19 pandemic and lockdown.

New Zealand shares edged lower as investors became wary of a market correction ahead of earnings results from some of the United States’ biggest listed companies.

New Zealand shares had a soft start to the week as building tensions between the US and China stoked demand for defensive assets such as gold, which hit an all-time high.

New Zealand shares fell as the prospect of heightened tensions between the US and China weighed on the global economic outlook and prospects for corporate earnings.

New Zealand shares fell, led lower by Oceania Healthcare after it reported annual earnings significantly weaker due to covid-19.

New Zealand shares edged lower as the two biggest companies - Fisher & Paykel Healthcare and A2 Milk - weighed on the broader index, following Australia lower amid concerns over the latest wave of new covid-19 cases across the Tasman.